NDC00310-0720-10
View detailed technical data, stock status, and sourcing information for: NDC00310-0720-10
DODParts.com distributes related products varnishes dopes paints, aircraft parts and consumables, electrical parts, fittings and other components for the aerospace and defense industries. Submit the short price quote form for part NDC00310-0720-10 to receive an up to date pricing and availability quote by email.
A resistor whose ohmic value cannot be adjusted or varied. The resistor element consists of either a thin layer or conductive material, containing neither binders or insulating materials, deposited on an insulated form, or an alloy of metal and ceramic materials, usually fused to an insulated form. Opposition to the flow of current is an inherent property of the materials used and is manifest by the heat dissipation in the resistor. Primarily intended for incorporation into microelectronic circuits and surface mounted applications.
fulvestrant injection: 250 mg of active ingredient per 5 ml, (50 mg/ml), 2 pre filled glass syringes; for im administration; single patient use; both syringes must be used to receive the 500 mg dose; requires refrig btwn 2-8 degrees c; do not freeze; protect from light; store in the original carton until time of use; hazardous contains ethyl alcohol and benzyl alcohol; used for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy special features, fulvestrant injection 250 mg per 5 ml (50 mg/ml), 2 pre-filled syringes part name assigned by controlling agency
Product Characteristics
Below you’ll find the complete technical specifications and performance data for this part, including material details and compliance information.
- Part Name Assigned By Controlling Agency
- fulvestrant injection 250 mg per 5 ml (50 mg/ml), 2 pre-filled syringes
- Special Features
- fulvestrant injection: 250 mg of active ingredient per 5 ml, (50 mg/ml), 2 pre filled glass syringes; for im administration; single patient use; both syringes must be used to receive the 500 mg dose; requires refrig btwn 2-8 degrees c; do not freeze; protect from light; store in the original carton until time of use; hazardous contains ethyl alcohol and benzyl alcohol; used for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy
Related Parts
This NSN group includes multiple components designed to meet specific performance and operational standards. Each listing provides detailed specs, functionality data, and replacement compatibility information:
| Part Number | Name |
|---|---|
| 1484575 | Fulvestrant Injection |
| 6505NCM173720 | Fulvestrant Injection |
| FASLODEX | Fulvestrant Injection |
| NDC00310-0720-10 | Fulvestrant Injection |
FAQs
Find helpful answers about installation, operation, maintenance, compliance, and troubleshooting.
What is the FSCG of the NSN 6505-01-666-4009?
Does NSN 6505-01-666-4009 require demilitarization?
Does NSN 6505-01-666-4009 contain precious materials?
Does NSN 6505-01-666-4009 contain hazardous materials?
When the NSN 6505-01-666-4009 was assigned to the Federal Catalog?
Professional Distribution
Certified to meet the strict requirements of defense, aerospace, and hazardous materials distribution.
- ITAR Registered
- DDTC Registered
- HAZMAT Certified
- AS9120 Quality Standards
- 100% Quality Inspections
You May Also Like
Browse other in-demand NSN parts sourced by professionals in defense, aerospace, and manufacturing sectors. Each component meets strict standards for quality and performance.
Pricing
Submit your request below and our team will respond quickly with up-to-date pricing, delivery estimates, and stock information: